Thirteen (13) SAMU-supported manuscripts were published in peer-reviewed journals in the second quarter alone, eighteen (18) since the beginning of the year . These included five original papers, two short communications, two meta-analyses, one modelling and three opinion papers.

q2
Title
Bedaquiline and delamanid in combination for treatment of drugresistant tuberculosis
Version
Q2, 2019
q2
Title
Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study
Version
Q2, 2019
Q2
Title
Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment
Version
Q2, 2019
q2, 2019
Title
The STREAM trial: missed opportunities and lessons for future clinical trials
Version
Q2, 2019
Q2
Title
Investigating the addition of oral HIV self-tests among populations with high testing coverage
Version
Q2, 2019
Q2
Title
Outcomes of patients in clubs after recent viral suppression
Version
Q2, 2019
Q2
Title
Simplifying switch to second-line antiretroviral therapy
Version
Q2, 2019
Q2
Title
Breast Tuberculosis in Women: A systematic Review
Version
Q2, 2019
Q2
Title
The missed potential of CD4 and viral load testing
Version
Q2, 2019
Q2 2019
Title
ART adherence clubs in Khayelitsha and Gugulethu
Version
Q2, 2019
Q2
Title
HIV virological failure in Mozambique
Version
Q2, 2019
Q2
Title
Performance of Cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure
Version
Q2, 2019
Q2
Title
Universal regimens or universal access to drug susceptibility testing for tuberculosis?
Version
Q2, 2019